Published in Nat Med on December 19, 2016
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
Rapid evolution of RNA genomes. Science (1982) 14.76
EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol (2006) 14.70
On the entry of Semliki forest virus into BHK-21 cells. J Cell Biol (1980) 11.05
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med (2015) 5.16
An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg (1955) 4.83
Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet (2016) 3.14
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest (2010) 2.92
Evolutionary relationships and systematics of the alphaviruses. J Virol (2001) 2.84
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med (2010) 2.62
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg (2000) 2.39
Transcontinental movement of Asian genotype chikungunya virus. Emerg Infect Dis (2014) 2.15
Zika virus: History, emergence, biology, and prospects for control. Antiviral Res (2016) 2.13
The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol (2006) 2.09
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92
DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol (2003) 1.91
Averaging tens to hundreds of icosahedral particle images to resolve protein secondary structure elements using a Multi-Path Simulated Annealing optimization algorithm. J Struct Biol (2007) 1.90
Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis (2013) 1.86
4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J (2011) 1.77
Unprecedented genomic diversity of RNA viruses in arthropods reveals the ancestry of negative-sense RNA viruses. Elife (2015) 1.76
Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine (1986) 1.74
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine (2008) 1.67
Formation of nsP3-specific protein complexes during Sindbis virus replication. J Virol (2006) 1.63
Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog (2011) 1.62
Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J Virol (2003) 1.54
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Vaccine (2009) 1.32
Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol (2012) 1.31
Chimeric Sindbis-Ross River viruses to study interactions between alphavirus nonstructural and structural regions. J Virol (1996) 1.28
Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus. Vaccine (2012) 1.21
Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication. Proc Natl Acad Sci U S A (2012) 1.20
Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. J Infect Dis (2014) 1.15
Viscerotropic disease following yellow fever vaccination in Peru. Vaccine (2009) 1.11
Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization. Elife (2013) 1.10
Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology (2003) 1.06
Insect-Specific Virus Discovery: Significance for the Arbovirus Community. Viruses (2015) 1.06
Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol (1997) 1.03
Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis (2014) 1.02
Eilat virus host range restriction is present at multiple levels of the virus life cycle. J Virol (2014) 0.94
Effect of formaldehyde inactivation on poliovirus. J Virol (2014) 0.93
Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures. Appl Microbiol (1972) 0.91
Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection. PLoS Negl Trop Dis (2015) 0.89
Immunogenicity of purified, inactivated chikungunya virus in monkeys. Bull World Health Organ (1973) 0.85
Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells. Virology (1995) 0.79
Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III. PLoS Negl Trop Dis (2015) 0.78
Visualizing dengue virus through Alexa Fluor labeling. J Vis Exp (2011) 0.76